EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma

Anusha Shreenidhi Bhat, Ningthoujam Anirudh Singh, Emdormi Rymbai, Swapna Birendra, Saravanan Jayaram, Divakar Selvaraj iD

Reproductive Sciences · 2023-05 · 30 (5) · 1383-1398

DOI: 10.1007/s43032-022-01064-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproductive Sciences, online erschienen am 15.08.2022. Verfasst von Anusha Shreenidhi Bhat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India. Hauptthemen laut MEDLINE: Leiomyoma, Uterine Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 134 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine fibroid or leiomyoma is the most common benign uterus tumor. The tumor is primarily composed of smooth muscle (fibroid) cells, myofibroblast, and a significant amount of extracellular matrix components. It mainly affects women of reproductive age. They are uncommon before menarche and usually disappear after menopause. The fibroids have excessive extracellular matrix components secreted by activated fibroblast cells (myofibroblast). Myofibroblast has the characteristics of fibroblast and smooth muscle cells. These cells possess contractile capability due to the expression of contractile proteins which are normally found only in muscle tissues. The rigid nature of the tumor is responsible for many side effects associated with uterine fibroids. The current drug treatment strategies are primarily hormone-driven and not anti-fibrotic. This paper emphasizes the fibrotic background of uterine fibroids and the mechanisms behind the deposition of excessive extracellular matrix components. The transforming growth factor-β, hippo, and focal adhesion kinase-mediated signaling pathways activate the fibroblast cells and deposit excessive extracellular matrix materials. We also exemplify how dipeptidyl peptidase-4 and fibroblast activation protein inhibitors could be beneficial in reducing the fibrotic process in leiomyoma. Dipeptidyl peptidase-4 and fibroblast activation protein inhibitors prevent the fibrotic process in organs such as the kidneys, lungs, liver, and heart. These inhibitors are proven to inhibit the signaling pathways mentioned above at various stages of their activation. Based on literature evidence, we constructed a narrative review on the mechanisms that support the beneficial effects of dipeptidyl peptidase-4 and fibroblast activation protein inhibitors for treating uterine fibroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaUterine NeoplasmsFemaleHumansFibroblastsFibrosisDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Stichwörter der Autor:innen

Dipeptidyl peptidase-4Fibroblast activation proteinFibrosisLeiomyomaTransforming growth factor-βUterine fibroid

Substanzen

Dipeptidyl-Peptidases and Tripeptidyl-Peptidases

Autor:innen und Institutionen

  • Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India.
  • Department of Pharmacology, Government College of Pharmacy, Bangalore, Karnataka, India.
  • Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India. diva.niru@gmail.com.

ORCID-Profile: Divakar Selvaraj

Zitieren

APA

Bhat, A. S., Singh, N. A., Rymbai, E., Birendra, S., Jayaram, S., & Selvaraj, D. (2023). Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma. Reproductive Sciences, 30(5), 1383-1398. https://doi.org/10.1007/s43032-022-01064-0

Vancouver

Bhat AS, Singh NA, Rymbai E, Birendra S, Jayaram S, Selvaraj D. Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma. Reproductive Sciences. 2023;30(5):1383-1398. doi:10.1007/s43032-022-01064-0

BibTeX
@article{Bhat2023,
  author = {Bhat, Anusha Shreenidhi and Singh, Ningthoujam Anirudh and Rymbai, Emdormi and Birendra, Swapna and Jayaram, Saravanan and Selvaraj, Divakar},
  title = {Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma},
  journal = {Reproductive Sciences},
  year = {2023},
  volume = {30},
  number = {5},
  pages = {1383--1398},
  doi = {10.1007/s43032-022-01064-0}
}
Kostenlos starten →